Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
10/15MERCK : And Co. Gets European Medicines Agency's Positive Opinions on Pneumonia Vaccine, C..
MT
10/15MERCK : Receives Positive Opinions From European Medicines Agency on Pneumonia Vaccine, Ca..
MT
10/15Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers
DJ
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA« (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/15Merck Gets CHMP Positive Opinion for Vaxneuvance Vaccine
DJ
10/15MERCK : US FDA To Review Merck & Co.'s COVID-19 Antiviral Drug For Approval In Late Novemb..
MT
10/14MERCK : FDA to Review Merck's Emergency Use Authorization Request For Molnupiravir COVID-1..
MT
10/14MERCK : Nov 30th FDA Advisory Committee meeting to Discuss Merck & Ridgeback's COVID-19 An..
MT
10/14MERCK : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Co..
MT
10/13MERCK : FDA Approves Merck's KEYTRUDA« (pembrolizumab) Plus Chemotherapy, With or Without ..
BU
10/12MERCK : EU Eyeing Supply Deal With Merck and Co. For COVID-19 Pill
MT
10/12MERCK : Morgan Stanley Adjusts Price Target on Merck & Company to $88 From $85, Maintains ..
MT
10/12Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene T..
CI
10/12MERCK : Launches Tender Offer to Buy Acceleron Pharma at $180 Per Share
MT
More most relevant news
All news about MERCK & CO., INC.
10/15MERCK : And Co. Gets European Medicines Agency's Positive Opinions on Pneumonia Vaccine, C..
MT
10/15MERCK : Receives Positive Opinions From European Medicines Agency on Pneumonia Vaccine, Ca..
MT
10/15Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers
DJ
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA« (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/15Merck Gets CHMP Positive Opinion for Vaxneuvance Vaccine
DJ
10/15MERCK : US FDA To Review Merck & Co.'s COVID-19 Antiviral Drug For Approval In Late Novemb..
MT
10/14MERCK : FDA to Review Merck's Emergency Use Authorization Request For Molnupiravir COVID-1..
MT
10/14MERCK : Nov 30th FDA Advisory Committee meeting to Discuss Merck & Ridgeback's COVID-19 An..
MT
10/14MERCK : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Co..
MT
More news
News in other languages on MERCK & CO., INC.
10/15Merck And Co. Obtention d'avis positifs de l'Agence européenne des médicaments sur un v..
10/15MERCK : le CHMP a accordé des avis positifs
10/15Merck & Co erhält EU-Zulassungsemfehlung bei Krebsmittel
10/15La FDA américaine examinera le médicament antiviral COVID-19 de Merck & Co. en vue d'un..
10/14La FDA examinera la demande d'autorisation d'utilisation d'urgence de Merck pour le méd..
10/14Un actionnaire d'Acceleron Pharma affirme que l'offre de Merck & Co. sous-évalue consid..
10/12MÄRKTE USA/Etwas leichter - Anleger vor Berichtssaison in Wartestellung
10/12Selon Morgan Stanley, Pfizer et Merck devraient revoir leurs perspectives à la hausse d..
10/12MÄRKTE USA/Börsen treten auf der Stelle
10/12L'UE envisage un accord de fourniture avec Merck and Co. pour la pilule COVID-19
More news
Analyst Recommendations on MERCK & CO., INC.
10/12MERCK : Morgan Stanley Adjusts Price Target on Merck & Company to $88 From $85, Maintains ..
MT
10/08MERCK : Barclays Adjusts Merck & Co.'s Price Target to $92 from $87, Keeps Overweight Rati..
MT
10/08MERCK : Receives Price Target Boost to $92 From $86 From Berenberg Bank; Hold Rating Maint..
MT
10/05ANALYST RECOMMENDATIONS : Chipotle Mexican Grill, Coherent, Merck, Microchip Technology, V..
10/04MERCK : Atlantic Equities Adjusts Merck & Company PT to $100 From $92, Maintains Overweigh..
MT
More recommendations
Press releases
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA« (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/13MERCK : FDA Approves Merck's KEYTRUDA« (pembrolizumab) Plus Chemotherapy, With or Without ..
BU
10/13Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV (enfo..
AQ
10/12MERCK : Begins Tender Offer to Acquire Acceleron Pharma Inc.
BU
More press releases
Upcoming event on MERCK & CO., INC.